These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27447084)

  • 1. Progestin isoforms provide different levels of protein S expression in HepG2 cells.
    Kozuka T; Tamura S; Kawamura N; Nakata Y; Hasebe R; Makiyama A; Takagi Y; Murata M; Mizutani N; Takagi A; Kojima T
    Thromb Res; 2016 Sep; 145():40-5. PubMed ID: 27447084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
    Lete I; Chabbert-Buffet N; Jamin C; Lello S; Lobo P; Nappi RE; Pintiaux A
    Eur J Contracept Reprod Health Care; 2015; 20(5):329-43. PubMed ID: 26007631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestin-only contraception and venous thromboembolism.
    Blanco-Molina MA; Lozano M; Cano A; Cristobal I; Pallardo LP; Lete I
    Thromb Res; 2012 May; 129(5):e257-62. PubMed ID: 22425318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis.
    Bateson D; Butcher BE; Donovan C; Farrell L; Kovacs G; Mezzini T; Raynes-Greenow C; Pecoraro G; Read C; Baber R
    Aust Fam Physician; 2016; 45(1):59-64. PubMed ID: 27051991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestin-only contraception and thromboembolism: A systematic review.
    Tepper NK; Whiteman MK; Marchbanks PA; James AH; Curtis KM
    Contraception; 2016 Dec; 94(6):678-700. PubMed ID: 27153743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal contraception and venous thromboembolism.
    Lidegaard Ø; Milsom I; Geirsson RT; Skjeldestad FE
    Acta Obstet Gynecol Scand; 2012 Jul; 91(7):769-78. PubMed ID: 22568831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of protein S by progestins.
    Hughes Q; Watson M; Cole V; Sayer M; Baker R; Staton J
    J Thromb Haemost; 2007 Nov; 5(11):2243-9. PubMed ID: 17958742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study.
    Barsoum MK; Heit JA; Ashrani AA; Leibson CL; Petterson TM; Bailey KR
    Thromb Res; 2010 Nov; 126(5):373-8. PubMed ID: 20833412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contraception, venous thrombosis and biological plausability.
    Rott H
    Minerva Med; 2013 Apr; 104(2):161-7. PubMed ID: 23514992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of thromboembolism associated with hormone contraceptives in Japanese compared with Western women.
    Kobayashi T; Sugiura K; Ojima T
    J Obstet Gynaecol Res; 2017 May; 43(5):789-797. PubMed ID: 28422361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].
    Botzenhardt S; Toni I; Rascher W; Neubert A
    Klin Padiatr; 2013 Sep; 225(5):268-76. PubMed ID: 23979828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestin type affects the increase of heparanase level and procoagulant activity mediated by the estrogen receptor.
    Treger S; Ackerman S; Kaplan V; Ghanem S; Nadir Y
    Hum Reprod; 2021 Jan; 36(1):61-69. PubMed ID: 33306105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk?
    Han L; Jensen JT
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):683-98. PubMed ID: 26598309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
    Dinger J; Bardenheuer K; Heinemann K
    Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal contraceptives and venous thromboembolism: an epidemiological update.
    Plu-Bureau G; Maitrot-Mantelet L; Hugon-Rodin J; Canonico M
    Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):25-34. PubMed ID: 23384743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.